retatrutide weight loss study results 🚨 Today, retatrutide, the GIP/GLP-1/glucagon triple agonist, just delivered TRIUMPH-2 top-line results. A in those with concurrent obesity and type 2 diabetes. 📊 Mean body change at 80 weeks: ⬇️ retatrutide weight loss phase 2

Individual states are addressing the issue by issuing warnings, restricting compounding pharmacies, and increasing oversight of telehealth companies involved in prescribing semaglutide

FDA-approved options like Wegovy and Zepbound are regulated and reliable but cost $900$1,500+ per month without insurance

GLP-1 medications can do more than lower blood glucose in type 2 diabetes they can also benefit the heart, kidneys, liver, and overall metabolic health

Answer: Retatrutide is an investigational once-weekly injectable peptide that activates three hormone receptor systems at once, GLP-1, GIP, and glucagon, to slow digestion, improve insulin response, and directly burn stored fat

Table of Contents What Are GLP-1 Drugs and How Do They Work

This article was written by Jayme L